Dr. David G. Bostwick Returns as Chief Executive Officer of Bostwick Laboratories

August 2016 - Bostwick Laboratories is pleased to announce that Bostwick Founder and Former Chief Executive Officer Dr. David G. Bostwick, MD, MBA, has returned to the role of Chief Executive Officer, effective immediately. Dr. Bostwick succeeds interim Chief Executive Officer Michael J. Parsons, former CEO of SouthernCare and COO of Triad Hospitals.

Dr. Bostwick is not only the founder of Bostwick Laboratories, but he is also considered the founding scientific leader of urologic anatomic pathology. His direction will help us continue to advance our position as one of the leading pathology service providers in the United States by offering the very best care and services to patients and their physicians.

Bostwick Laboratories’ strategy will remain the same – we will continue to grow by leveraging our best-in-class technical and scientific expertise to help physicians and patients make informed treatment decisions. We will also maintain our commitment to offering the very best service to our clients.

Dr. Bostwick is an internationally renowned urologic pathologist with more than 30 years of experience and interest in prostate cancer, bladder cancer and urologic diseases. He founded Bostwick in 1999 and has served in multiple capacities at the Company since its founding, including Chief Medical Officer, President, and Chief Executive Officer. Dr. Bostwick previously was a professor of urology and pathology at the Mayo Clinic. He holds a BA in Biological Sciences and an MD from the University of Maryland, and an MBA from Loyola College of Maryland.

For more information:  Contact Client Services at 877.865.3262